Covering: 2013. Previous review: Nat. Prod. Rep., 2014, 31, 160–258 This review covers the
literature published in 2013 for marine natural products (MNPs), with 982 citations (644 for …

Antimicrobial resistance is an exigent public health concern owing to the emergence of
novel strains of human resistant pathogens and the concurrent rise in multi-drug resistance …

A major goal in natural product discovery programs is to rapidly dereplicate known entities
from complex biological extracts. We demonstrate here that molecular networking, an …

Pharmaceutically important polyketides such as avermectin are mainly produced as
secondary metabolites during the stationary phase of growth of Streptomyces species in …

Natural products derived from marine microorganisms have received great attention as a
potential resource of new compound entities for drug discovery. The unique marine …

Covering: 2009 to 2013. This review covers the 188 novel marine natural products
described since 2008, from deep-water (50–> 5000 m) marine fauna including bryozoa …

Rare Actinomycetes from underexplored marine environments are targeted in drug
discovery studies due to the Actinomycetes' potentially huge resource of structurally diverse …

Deep sea is a unique and extreme environment. It is a hot spot for hunting marine
actinomycetes resources and secondary metabolites. The novel deep sea actinomycete …

[4+ 2]-Cycloadditions are increasingly being recognized in the biosynthetic pathways of
many structurally complex natural products. A relatively small collection of enzymes from …

Tuberculosis remains one of the world's deadliest communicable diseases, novel anti-
tuberculosis agents are urgently needed due to severe drug resistance and the co-epidemic …